Louisiana introduced HB 152 (2026) to add multiple specified opioids/synthetic opioids to Schedule I

Louisiana HB 152 (2026 Regular Session), as introduced, proposes to amend the Uniform Controlled Dangerous Substances Law by enacting new Schedule I opiate entries at R.S. 40:964(Schedule I)(A)(108) through (120). The proposal would add a list of specified opioids/synthetic opioids (including certain nitazenes and fentanyl analog-related substances) to Schedule I, and directs the Louisiana State Law Institute to alphabetize/renumber the schedule entries. If enacted, impacted organizations would need to update controlled-substance lists and compliance controls tied to Louisiana Schedule I status.